CervoMed
CRVO
12 hedge funds and large institutions have $839K invested in CervoMed in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
0.64% more ownership
Funds ownership: 5.97% → 6.6% (+0.64%)
8% less funds holding
Funds holding: 13 → 12 (-1)
9% less capital invested
Capital invested by funds: $924K → $839K (-$84.8K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$110K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.02K |
| 3 |
Renaissance Technologies
New York
|
+$1.77K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$869 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$80 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$665 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$20 |
| 3 |
CCM
Connective Capital Management
Palo Alto,
California
|
-$5 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $302K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $162K | +$1.77K | +200 | +0.8% |
|
3
BlackRock
New York
| $136K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $77.6K | +$110K | +12,438 | New |
|
5
Geode Capital Management
Boston,
Massachusetts
| $71.2K | – | – | – |
|
|
BCM
6
Bridgeway Capital Management
Houston,
Texas
| $68.9K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $14K | +$3.02K | +341 | +18% |
|
|
8
Osaic Holdings
Scottsdale,
Arizona
| $2.55K | +$80 | +9 | +2% |
|
9
Morgan Stanley
New York
| $2.27K | – | – | – |
|
|
10
UBS Group
Zurich,
Switzerland
| $1.95K | +$869 | +98 | +46% |
|
|
11
Wells Fargo
San Francisco,
California
| $58 | -$665 | -75 | -89% |
|
|
TF
12
TimeScale Financial
Danvers,
Massachusetts
| $37 | – | – | – |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$20 | -3 | Closed |
|
|
CCM
14
Connective Capital Management
Palo Alto,
California
| – | -$5 | -1 | Closed |
|
CRVO Hedge Fund Activity: Q1 2023 in Review
12 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q1 2023, worth a combined $839K — down 9.2% from $924K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CRVO and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 4 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $110K. The largest seller was Wells Fargo, cutting an estimated $665.
- 12 institutional investors held CervoMed (CRVO) as of Q1 2023, down from 13 in Q4 2022.
- Funds reported $839K of CervoMed stock for Q1 2023, down 9.2% quarter-over-quarter.
- 1 fund opened new CervoMed positions in Q1 2023 and 2 closed out, a net change of -1 holder.
- The largest CervoMed buyer in Q1 2023 was Citadel Advisors, an estimated $110K added.
- The largest CervoMed seller in Q1 2023 was Wells Fargo, an estimated $665 sold.
Based on aggregated 13F filings for Q1 2023.